Home
>
National Drug Code (NDC)
>
LAMISIL AT
LAMISIL AT - 0067-6239-21 - (TERBINAFINE)
Drug Information of LAMISIL AT
| Product NDC: | 0067-6239 |
| Proprietary Name: | LAMISIL AT |
| Non Proprietary Name: | TERBINAFINE |
| Active Ingredient(s): | 10 mg/g & nbsp; TERBINAFINE |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LAMISIL AT
| Product NDC: | 0067-6239 |
| Labeler Name: | Novartis Consumer Health, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA021958 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100101 |
Package Information of LAMISIL AT
| Package NDC: | 0067-6239-21 |
| Package Description: | 1 TUBE in 1 CONTAINER (0067-6239-21) > 6 g in 1 TUBE |
NDC Information of LAMISIL AT
| NDC Code | 0067-6239-21 |
| Proprietary Name | LAMISIL AT |
| Package Description | 1 TUBE in 1 CONTAINER (0067-6239-21) > 6 g in 1 TUBE |
| Product NDC | 0067-6239 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | TERBINAFINE |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20100101 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Consumer Health, Inc. |
| Substance Name | TERBINAFINE |
| Strength Number | 10 |
| Strength Unit | mg/g |
| Pharmaceutical Classes |
